First Time Loading...
P

Pear Therapeutics Inc
NASDAQ:PEAR

Watchlist Manager
Pear Therapeutics Inc
NASDAQ:PEAR
Watchlist
Price: 0.0077 USD -15.38% Market Closed
Updated: May 7, 2024
Section:
 

Wall Street
Price Targets

PEAR Price Targets Summary
Pear Therapeutics Inc

There are no price targets for PEAR.
PEAR Lowest Forecast
Wall Street Target
Not Available
PEAR Average Forecast
Wall Street Target
Not Available
PEAR Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Pear Therapeutics Inc Competitors:
Price Targets
SLP
Simulations Plus Inc
14% Upside
M7T
Mach7 Technologies Ltd
92% Upside
INS
Instem PLC
23% Upside
4483
JMDC Inc
70% Upside
SLP
Simulations Plus Inc
14% Upside
M7T
Mach7 Technologies Ltd
92% Upside
INS
Instem PLC
23% Upside
4483
JMDC Inc
70% Upside
CSAM
Csam Health Group AS
47% Upside
EVH
Evolent Health Inc
66% Upside
IUG
Intelligent Ultrasound Group PLC
128% Upside
2192
Medlive Technology Co Ltd
20% Upside

Revenue
Forecast

Revenue Estimate
Pear Therapeutics Inc

For the last 1 year the compound annual growth rate for Pear Therapeutics Inc's revenue is 202%. The projected CAGR for the next 1 year is 99%.

202%
Past Growth
99%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Pear Therapeutics Inc

Operating Income forecast
is not available for
Pear Therapeutics Inc

Net Income
Forecast

Net Income Estimate
Pear Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
PEAR intrinsic value, competitors valuation, and company profile.
DCF Valuation
PEAR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PEAR stock valuation using valuation multiples.
Wall Street Estimates
PEAR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PEAR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PEAR's stock price target?
Not Available

PEAR doesn't have any price targets made by Wall Street professionals.

What is Pear Therapeutics Inc's Revenue forecast?
Projected CAGR
99%

For the last 1 year the compound annual growth rate for Pear Therapeutics Inc's revenue is 202%. The projected CAGR for the next 1 year is 99%.

ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.